SOFIE is a company that aims to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics. They have a strong radiopharmaceutical production and distribution network, contract manufacturing services, and valuable theranostic intellectual property. They are committed to delivering radiopharmaceuticals from start to clinic.